The Revolutionary VivaGel Condoms are Designed to Kill HIV
References: starpharma & designtaxi
Australian firm Starpharma recently created the VivaGel condom that is designed to kill sexually transmitted diseases and HIV within the first moment of contact. This condom will revolutionize the lives of many suffering with HIV or incurable sexually transmitted diseases.
The VivaGel condom's ability to kill sexually transmitted diseases is in the lubricant that the condoms come coated in. The lubricant is made up from an anti-microbial drug called astodrimer sodium that is designed to combat HIV. This chemical drug has tested as 99.9% effective in killing HIV and sexually transmitted viruses. The condom is also highly effective at preventing pregnancy.
The VivaGel condom was inspired by the growing rise of HIV positive people in Australia.
The VivaGel condom's ability to kill sexually transmitted diseases is in the lubricant that the condoms come coated in. The lubricant is made up from an anti-microbial drug called astodrimer sodium that is designed to combat HIV. This chemical drug has tested as 99.9% effective in killing HIV and sexually transmitted viruses. The condom is also highly effective at preventing pregnancy.
The VivaGel condom was inspired by the growing rise of HIV positive people in Australia.
Trend Themes
1. Disease-eliminating Condom - The innovation of disease-eliminating condoms using anti-microbial drugs opens up the opportunity for the development of more innovative condoms utilizing different microbicides.
2. Sexual Health Technology - Developing innovative technology and creating a sustainable ecosystem that allows more partners, businesses and governments to contribute to promote sexual health is now more crucial than ever.
3. Preventative Measures Pandemic - In response to the COVID-19 pandemic, preventative measures and the need for shared responsibility to promote sexual health and wellness have become significant innovation opportunities.
Industry Implications
1. Contraceptive Manufacturing - The innovation of the VivaGel condom presents new opportunities for contraceptive manufacturing companies to collaborate with pharmaceuticals and integrate microbicide technologies to promote sexual health and wellness.
2. Pharmaceuticals - The innovative use of microbicides in VivaGel's anti-microbial drug can open up opportunities for pharmaceuticals to invest in research and development of similar technologies that promote health and protect against the transmission of disease.
3. Nonprofit Organizations Healthcare Services - Nonprofit organizations can now leverage the innovation of the VivaGel condom as part of their healthcare services and develop programs that empower communities to prioritize their sexual health and wellness.
2.6
Score
Popularity
Activity
Freshness
